FDA Inspection 1005520 — Kevin Martin
The FDA completed an inspection of Kevin Martin on March 24, 2017 in New Paris, IN. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 24, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- New Paris, IN (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 13521 | 21 CFR 530.41(a) | Drugs prohibited for extralabel use in food-producing animal(s) |
| 4093 | 21 CFR 530.11(d) | ELDU - producer causes Illegal drug residue |
| 4182 | FDCA 501(a)(5) | ELDU without veterinary client-patient relationship |
| 4185 | FDCA 402(a)(4) | Record keeping |